Premkumar Madhumita, Rangegowda Devaraja, Kulkarni Anand, Vyas Tanmay, Dudha Shivani, Maiwall Rakhi
Department of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, India.
J Clin Exp Hepatol. 2019 Nov-Dec;9(6):749-752. doi: 10.1016/j.jceh.2019.03.007. Epub 2019 Mar 27.
Recurrent pyogenic cholangitis (RPC) is a disease characterized by multiple strictures of the biliary tree, impaired biliary drainage, formation of intrahepatic biliary pigment stones and recurrent bouts of cholangitis. We report the case of a 39-year-old businessman with diagnosed chronic calcific pancreatitis, who presented to us with recurrent episodes of cholangitis, leading to portal pyaemia, and progressive liver failure, which could not be controlled despite adequate biliary drainage. The patient rapidly developed progressive liver failure and sepsis-related coagulation failure. He was also found to have idiopathic CD4+ T cell lymphocytopenia (ICL), which resulted in refractory sepsis and formation of metastatic abscesses in the lung and spleen. ICL is now recognised in patients with recurrent and difficult to treat opportunistic infections. The combination of RPC, sepsis and liver failure in the setting of an acquired immunosuppressed state makes this a unique management scenario.
复发性化脓性胆管炎(RPC)是一种以胆管树多处狭窄、胆汁引流受损、肝内胆管色素结石形成以及复发性胆管炎发作为特征的疾病。我们报告了一例39岁被诊断为慢性钙化性胰腺炎的商人病例,该患者因复发性胆管炎就诊于我们科室,导致门静脉脓毒症和进行性肝衰竭,尽管进行了充分的胆汁引流,病情仍无法得到控制。患者迅速出现进行性肝衰竭和脓毒症相关的凝血功能衰竭。他还被发现患有特发性CD4 + T细胞淋巴细胞减少症(ICL),这导致了难治性脓毒症以及肺和脾转移性脓肿的形成。ICL目前在患有复发性且难以治疗的机会性感染的患者中得到了认识。在获得性免疫抑制状态下,RPC、脓毒症和肝衰竭同时出现,使得这成为一种独特的治疗情况。